SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
US Stock Market Move | AI application software stocks fell, with Applovin (APP.US) dropping more than 9.7%
US Stock Market Move | Broadcom Inc. (AVGO.US) fell more than 4%. Debt repayment pressure caused investor concerns.
Performance soaring, controlling stake acquired in Dongyao Pharmaceutical, WUXI XDC (02268) further solidifies its position in the ADC CDMO market.
US Stock Market Move | AI application software stocks fell, with Applovin (APP.US) dropping more than 9.7%
US Stock Market Move | Broadcom Inc. (AVGO.US) fell more than 4%. Debt repayment pressure caused investor concerns.
Performance soaring, controlling stake acquired in Dongyao Pharmaceutical, WUXI XDC (02268) further solidifies its position in the ADC CDMO market.
